💬In plain words
What the trial is, and whether it could suit you
This study is to evaluate the safety and efficacy of dual-endoscope assisted sentinel lymph node navigation surgery for early gastric cancer (EGC).
Sign in to get the eligibility rules as simple questions to take to your doctor.
📋 Eligibility rules (as published)
Inclusion Criteria:
* Preoperative assessment indicating that the tumor was confined to the mucosa or submucosa, consistent with the diagnosis of early gastric cancer.
* Patients who required additional surgical intervention following initial endoscopic submucosal dissection (ESD) based on postoperative pathological evaluation.
* Patients and their families fully understood the procedure, requested dual-endoscope assisted sentinel lymph node navigation surgery, agreed to participate in this clinical study, and signed the informed consent form.
Exclusion Criteria:
* Preoperative assessment indicating suspected lymph node or distant metastasis.
* History of complex abdominal surgery rendering laparoscopic treatment infeasible.
* Participation in another clinical trial within 4 weeks prior to enrollment or currently participating in another trial.
* History of severe psychiatric disorders.
* Pregnant or lactating women.
* Uncontrolled infection prior to surgery.
* Presence of other malignancies or comorbidities that may significantly affect survival.
* Any other conditions deemed by the investigators as unsuitable for participation, or refusal by the patient or family to enroll.
* Cardiopulmonary, hepatic, and renal functions were unsufficient to tolerate the surgery.
💊
What it tests
- Laparoscopic-endoscopic cooperative surgery (LECS) Assisted Sentinel Lymph Node Navigation Surgery
the First Hospital of Jilin University
Changchun, China
the First Hospital of Jilin University
Ch’ang-ch’un, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.